Natural Killer Cells in Human Cancer: From Biological Functions to Clinical Applications
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Natural Killer Cells in Human Cancer: From Biological Functions to Clinical Applications
Authors
Keywords
-
Journal
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
Volume 2011, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2011-04-27
DOI
10.1155/2011/676198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Defective Infiltration of Natural Killer Cells in MICA/B-Positive Renal Cell Carcinoma Involves β2-Integrin-Mediated Interaction
- (2015) Giuseppe Sconocchia et al. NEOPLASIA
- Intracellular Retention of the NKG2D Ligand MHC Class I Chain-Related Gene A in Human Melanomas Confers Immune Privilege and Prevents NK Cell-Mediated Cytotoxicity
- (2014) M. B. Fuertes et al. JOURNAL OF IMMUNOLOGY
- IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR
- (2011) M. P. Roberti et al. BREAST CANCER RESEARCH AND TREATMENT
- Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers
- (2010) Lei Wu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
- (2010) Eleni G. Iliopoulou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lenalidomide in Nonmetastatic Biochemically Relapsed Prostate Cancer: Results of a Phase I/II Double-Blinded, Randomized Study
- (2010) D. Keizman et al. CLINICAL CANCER RESEARCH
- Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
- (2010) D. Cho et al. CLINICAL CANCER RESEARCH
- Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
- (2010) Tolga Sutlu et al. CYTOTHERAPY
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma
- (2010) M. Watanabe et al. DISEASES OF THE ESOPHAGUS
- Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC)
- (2010) Pierpaolo Correale et al. EUROPEAN JOURNAL OF CANCER
- Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression
- (2010) Véronique Decot et al. EXPERIMENTAL HEMATOLOGY
- High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
- (2010) Jan Spanholtz et al. PLoS One
- Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases
- (2009) MAYA GULUBOVA et al. APMIS
- Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells
- (2009) Gordana Konjević et al. BIOMARKERS
- CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells
- (2009) T. Baessler et al. BLOOD
- Interleukin-21 can efficiently restore impaired antibody-dependent cell-mediated cytotoxicity in patients with oesophageal squamous cell carcinoma
- (2009) M Watanabe et al. BRITISH JOURNAL OF CANCER
- Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
- (2009) Miroslaw J. Szczepanski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Natural killer cells remember: An evolutionary bridge between innate and adaptive immunity?
- (2009) Joseph C. Sun et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Safety analysis ofex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study
- (2009) Lisbeth Barkholt et al. Immunotherapy
- Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells
- (2009) Estrella Mariel Levy et al. Innate Immunity
- Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
- (2009) Frédéric Bibeau et al. JOURNAL OF CLINICAL ONCOLOGY
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
- (2009) M. Carlsten et al. JOURNAL OF IMMUNOLOGY
- The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-ras Mutation Status: Analysis of a Phase III Study of Bevacizumab with Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
- (2009) H. I. Hurwitz et al. ONCOLOGIST
- Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells
- (2009) Gal Markel et al. PLoS One
- The impact of Fc engineering on an anti-CD19 antibody: increased Fc receptor affinity enhances B-cell clearing in nonhuman primates
- (2008) J. Zalevsky et al. BLOOD
- HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism
- (2008) T. Kawase et al. BLOOD
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- Potent In vitro and In vivo Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia
- (2008) H. M. Horton et al. CANCER RESEARCH
- Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity
- (2008) Masayasu Hara et al. CANCER SCIENCE
- Lenalidomide Enhances Natural Killer Cell and Monocyte-Mediated Antibody-Dependent Cellular Cytotoxicity of Rituximab-Treated CD20+ Tumor Cells
- (2008) L. Wu et al. CLINICAL CANCER RESEARCH
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
- Potential Role of NK Cells in the Induction of Immune Responses: Implications for NK Cell–Based Immunotherapy for Cancers and Viral Infections
- (2008) Hiroshi Terunuma et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer
- (2007) G. Esendagli et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now